Good News for 'Bubble Babies'and California Stem Cell Agency -- With an Asterisk
The New England Journal of Medicine this morning carried a bit of good news for the California stem cell agency, UCLA, researcher Donald Kohn and a British firm called Orchard Therapeutics.
The piece puts an official seal on the success rate of a treatment for what is colloquially described as the bubble baby disease -- an immune deficiency affliction k…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.